Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sinergi Inti Plastindo Tbk. (ESIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Sinergi Inti Plastindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 1.6K 24h volume), while Sinergi Inti Plastindo Tbk. trades at Rp123 (market cap 135.41B, 735.9K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.4× Sinergi Inti Plastindo Tbk.'s market cap, and Sinergi Inti Plastindo Tbk. is more actively traded (735.9K versus 1.6K). Which is the better fit depends on your goals.
| DGNS | ESIP | |
|---|---|---|
Market Cap | 319B | 135.41B |
Volume | 1.6K | 735.9K |
Lot | 16 | 7.36K |
Turnover | 368.8K | 90.23M |
Average Price | 230.5 | 122.61 |
Value | 368.8K | 90.23M |
Indicative Equilibrium Price | 232 | 123 |
Indicative Equilibrium Volume | 200 | 1.43K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Sinergi Inti Plastindo Tbk.
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →
